A Complete Guide for UK Dental Practices

Introduction

In modern dental practice across the UK, clinicians are increasingly encountering patients taking immunosuppressant medications and biologic therapies. These drugs, commonly prescribed for conditions such as rheumatoid arthritis, inflammatory bowel disease, psoriasis, and post-transplant care, significantly alter the patient’s immune response.

For dental professionals, this presents a unique set of challenges. From increased infection risk to delayed healing and complex prescribing considerations, understanding these medications is no longer optional—it is essential for safe and effective care.

This comprehensive guide explores three commonly encountered immunosuppressive medications:

• Methotrexate

• Adalimumab

• Azathioprine

We will examine their mechanisms, dental implications, risks, and best practice management in line with UK dental guidelines (including SDCEP principles and antimicrobial stewardship guidance).

---

Why Immunosuppressants Matter in Dentistry

Immunosuppressants reduce or modulate the body's immune system. While this is beneficial for controlling autoimmune disease, it has several implications in dentistry:

Key Risks for Dental Patients

• Increased susceptibility to oral and systemic infections

• Reduced ability to fight odontogenic infections

• Delayed wound healing following extractions or surgery

• Potential for drug interactions with commonly prescribed dental medications

• Increased risk of oral ulceration or mucosal changes

With the growing use of biologics and long-term immunomodulatory therapy in the UK population, dental teams must adopt a proactive and informed approach.

---

Overview of Common Immunosuppressants and Biologics

1. Methotrexate

What is Methotrexate?

Methotrexate is a disease-modifying antirheumatic drug (DMARD) widely used for:

• Rheumatoid arthritis

• Psoriasis

• Certain cancers (at higher doses)

It works by inhibiting folate metabolism, reducing immune cell proliferation.

---

2. Adalimumab

What is Adalimumab?

Adalimumab is a biologic agent (anti-TNF therapy) used in:

• Rheumatoid arthritis

• Crohn’s disease

• Ulcerative colitis

• Psoriasis

It suppresses tumour necrosis factor (TNF), a key inflammatory mediator.

---

3. Azathioprine

What is Azathioprine?

Azathioprine is an immunosuppressive agent used in:

• Organ transplant patients

• Autoimmune diseases

• Inflammatory bowel disease

It inhibits purine synthesis, reducing white blood cell production.

---

Dental Implications of Immunosuppressants

1. Increased Infection Risk

Patients taking these medications are at higher risk of:

• Acute dental infections

• Opportunistic oral infections (e.g. candidiasis)

• Rapid progression of periodontal disease

Even minor infections can escalate more quickly.

---

2. Delayed Healing

Healing following:

• Extractions

• Periodontal surgery

• Implant placement

may be slower and less predictable.

---

3. Bone Marrow Suppression

Particularly relevant with methotrexate and azathioprine, which can cause:

• Neutropenia

• Thrombocytopenia

• Anaemia

This increases risk of:

• Infection

• Bleeding

• Ulceration

---

4. Drug Interactions

Certain antibiotics and analgesics commonly used in dentistry may interact:

• Trimethoprim + Methotrexate → severe bone marrow suppression (avoid)

• NSAIDs + Methotrexate → increased toxicity risk

• Metronidazole → caution with immunocompromised patients

---

Signs and Symptoms: What Dentists Should Look For

Below is a structured table for quick reference in clinical settings:

Oral and Systemic Signs in Patients on Immunosuppressants

---

Methotrexate and Dentistry

Key Dental Considerations

• Weekly dosing (important to confirm—errors can be dangerous)

• Monitor for:

  • Oral ulceration

  • Bone marrow suppression

• Avoid prescribing trimethoprim or co-trimoxazole

Dental Management

• Routine dental care is generally safe if:

  • Patient is stable

  • Blood counts are within normal limits

• Liaise with GP or specialist if:

  • Patient reports recent dose changes

  • There are signs of toxicity

---

Adalimumab and Dentistry

Key Dental Considerations

• Increased susceptibility to:

  • Serious infections

  • Delayed healing

• No direct bone marrow suppression, but immune response is reduced

Dental Management

• Routine care usually safe

• For invasive procedures:

  • Assess infection risk carefully

  • Ensure excellent oral hygiene pre-operatively

• Consider timing treatment midway between injections (where possible, though evidence is limited)

---

Azathioprine and Dentistry

Key Dental Considerations

• Risk of:

  • Bone marrow suppression

  • Infection

• Monitor for:

  • Oral ulcers

  • Signs of infection

Dental Management

• Check for:

  • Recent blood tests (if available)

• Avoid unnecessary trauma

• Be cautious with prescribing interacting drugs

---

Antibiotic Prescribing in Immunosuppressed Patients

Key Principles (Aligned with UK Guidance)

• Follow SDCEP antimicrobial prescribing guidance

• Avoid routine prophylactic antibiotics unless clearly indicated

• Prescribe antibiotics only when there is evidence of spreading infection or systemic involvement

Important Considerations

• Choose antibiotics carefully to avoid interactions

• Monitor closely for:

  • Poor response to treatment

  • Rapid deterioration

---

Dental Treatment Planning Considerations

Before Treatment

• Take a comprehensive medical history

• Identify:

  • Drug type

  • Dose

  • Duration

• Ask about:

  • Recent infections

  • Blood test results (if relevant)

---

During Treatment

• Use atraumatic techniques

• Maintain strict cross-infection control

• Minimise surgical intervention where possible

---

After Treatment

• Provide clear post-operative instructions

• Monitor healing closely

• Arrange follow-up where needed

---

When to Seek Medical Advice

Contact the patient’s GP or specialist if:

• Signs of bone marrow suppression

• Unexplained oral ulceration

• Persistent infection

• Planned extensive oral surgery

---

Red Flags for Dental Teams

Be alert for:

• Severe oral ulceration

• Unusual bleeding

• Rapidly spreading infection

• Systemic symptoms (fever, malaise)

These may require urgent referral.

---

Preventive Dentistry is Key

For patients on immunosuppressants, prevention is critical:

• Regular dental examinations

• Early intervention for caries and periodontal disease

• Reinforcement of:

  • Oral hygiene

  • Diet advice

• Fluoride use where appropriate

---

Communication with Patients

Patients may not always understand the dental implications of their medication.

Explain clearly:

• Why they are at increased risk

• Importance of early reporting of symptoms

• Need for regular dental visits

---

The Role of the Dental Team

All members of the dental team should be aware of:

• Medical history implications

• Infection control importance

• Early recognition of complications

This includes:

• Dentists

• Dental hygienists

• Dental nurses

---

Key Takeaways

For quick reference:

• Immunosuppressants increase infection risk and delay healing

• Common drugs include:

  • Methotrexate

  • Adalimumab

  • Azathioprine

• Avoid drug interactions, especially with methotrexate

• Follow UK antimicrobial prescribing guidelines

• Prevention and early intervention are essential

---

Frequently Asked Questions (FAQ)

Can patients on immunosuppressants have dental treatment?

Yes, most routine dental care is safe, but careful assessment is required.

---

Should antibiotics be given routinely?

No. Antibiotics should only be prescribed when clinically indicated, in line with UK guidance.

---

Are extractions safe?

Yes, but healing may be slower, and infection risk is higher. Careful planning is required.

---

What is the biggest risk?

The most significant risk is infection, which may progress rapidly.

---

Conclusion

As immunosuppressant and biologic therapies become more prevalent, UK dental professionals must adapt their approach to patient care. Understanding the implications of medications such as methotrexate, adalimumab, and azathioprine is essential for ensuring safe, effective, and patient-centred treatment.

By focusing on risk assessment, prevention, careful prescribing, and interprofessional communication, dental teams can confidently manage these patients and minimise complications.